Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by AGF Management Ltd.

AGF Management Ltd. cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 34.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 19,486 shares of the pharmacy operator’s stock after selling 10,463 shares during the quarter. AGF Management Ltd.’s holdings in Walgreens Boots Alliance were worth $509,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after buying an additional 10,962,030 shares in the last quarter. Invesco Ltd. raised its stake in shares of Walgreens Boots Alliance by 21.5% during the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after purchasing an additional 3,013,807 shares during the period. Morgan Stanley lifted its position in shares of Walgreens Boots Alliance by 15.8% during the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after purchasing an additional 1,720,228 shares in the last quarter. International Assets Investment Management LLC boosted its stake in shares of Walgreens Boots Alliance by 1,985.1% in the fourth quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock valued at $23,226,000 after purchasing an additional 846,884 shares during the period. Finally, Grantham Mayo Van Otterloo & Co. LLC grew its holdings in Walgreens Boots Alliance by 85.1% during the 3rd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 1,752,170 shares of the pharmacy operator’s stock valued at $38,968,000 after purchasing an additional 805,332 shares in the last quarter. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Price Performance

WBA opened at $17.89 on Thursday. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $19.02 and its 200 day moving average price is $21.37. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.12 and a fifty-two week high of $32.89. The firm has a market cap of $15.43 billion, a price-to-earnings ratio of -2.56, a price-to-earnings-growth ratio of 1.12 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter last year, the business posted $1.16 EPS. The business’s revenue was up 6.3% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be issued a $0.25 dividend. The ex-dividend date is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.59%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Analysts Set New Price Targets

A number of equities analysts have commented on WBA shares. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Truist Financial restated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. UBS Group dropped their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. Finally, HSBC reiterated a “reduce” rating and set a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $24.36.

View Our Latest Report on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.